Publications

Licensing out: Try not to get benched

par Colin McCall et Justyna Ostrowska-Krupa

UK increases scrutiny of tech and life sciences deals

Mergers and acquisitions in the tech and life sciences sectors may be subject to closer scrutiny by the UK competition authority and by the UK government in future.

par Paolo Palmigiano

6 de 6 Publications

Legal advice privilege: where are we now?

par Georgina Jones

Brexit and MDR readiness for overseas medical devices manufacturers: where should you locate your sales operations in Europe?

par Alison Dennis

Arbitration for life sciences companies

par Tasmina Goraya, PhD et Colin McCall

Territorial licensing: "start at the end before you begin"

par Colin McCall et Justyna Ostrowska-Krupa

A missed chance

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

An exploration of patent pools, R&D and current initiatives.

2 de 6 Publications

COVID-19 and life sciences M&A

par plusieurs auteurs

Special approvals of the Federal Institute for Drugs and Medical Devices for the distribution of medical devices and FFP breathing masks without an expiration valve

par Dr. Daniel Tietjen